CellaVision Annual General Meeting 2026 will take place on April 28 in Lund

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

Shareholders who wish to participate in the AGM shall be registered in the share register maintained by Euroclear Sweden AB no later than on 20 April 2026 and shall have notified the Company of their intention to participate at the AGM no later than on 22 April 2026. Notice to participate shall be given in writing by e-mail to cellavision@fredersen.se or by post to CellaVision AB (publ), c/o Fredersen Advokatbyrå, Neptunigatan 82, 211 18 Malmö. The notice shall contain the shareholder’s name, address, personal identity number or registration number and telephone number and, where applicable, the number of advisors (maximum two).

Attachments

CellaVision AB - Notice AGM 2026.pdf CellaVision AB - Kallelse ÅS 2026.pdf CellaVision AB - Proxy form.pdf CellaVision AB - Fullmaktsformulär.pdf CellaVision Remuneration Report 2025.pdf CellaVision Ersättningsrapport 2025.pdf The Board's proposal on authorization for the Board to repurchase and transfer own shares (item 19).PDF Styrelsens fullständiga förslag förvärv och återköp egna aktier (punkt 19).PDF The Board's motivated statement pursuant to 19.22.PDF Styrelsens motiverade yttrande enl. 19.22.pdf Proposal of the board of directors distribution of profits.PDF Revisorsyttrande.pdf